Natco Pharma trades with traction on the bourses

31 Jan 2017 Evaluate

Natco Pharma is currently trading at Rs. 690.00, up by 29.75 points or 4.51% from its previous closing of Rs. 660.25 on the BSE.

The scrip opened at Rs. 680.00 and has touched a high and low of Rs. 700.00 and Rs. 671.30 respectively. So far 61517 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 703.95 on 25-Aug-2016 and a 52 week low of Rs. 390.00 on 29-Mar-2016.

Last one week high and low of the scrip stood at Rs. 700.00 and Rs. 606.50 respectively. The current market cap of the company is Rs. 12044.67 crore.

The promoters holding in the company stood at 51.24%, while institutions and non-institutions held 26.02% and 22.74% respectively.

United States Food & Drug Administration (USFDA) has conducted an inspection at Natco Pharma’s formulations facility in Kothur, near Hyderabad, between January 16-24, 2017. At the end of the inspection, the facility received six observations, all of which are correctable and procedural, and which the company believes are minor in nature. The observations are related to complaint and incident investigations, stability backlog and procedural SOP's.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

975.35 6.25 (0.64%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1505.20
Dr. Reddys Lab 5922.45
Cipla 1339.45
Zydus Lifesciences 983.05
Lupin 1609.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.